Christopher John Morl, Chief Business Officer at Deciphera Pharmaceuticals, Inc. (DCPH), sold 30,274 shares at $57.74 ($1.8M) on 2020-01-02, disclosed to the SEC on 2020-01-06.
Open-market sale of $1.8M DCPH by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $57.74 | 8,505 | $491K | 27.8% |
| 2 | $57.74 | 8,505 | $491K | 27.8% |
| 3 | $58.38 | 3,529 | $206K | 11.7% |
| 4 | $58.38 | 3,529 | $206K | 11.7% |
| 5 | $59.48 | 2,103 | $125K | 7.1% |
| 6 | $59.48 | 2,103 |
| $125K |
| 7.1% |
| 7 | $60.58 | 800 | $48K | 2.7% |
| 8 | $61.58 | 800 | $49K | 2.8% |
| 9 | $62.25 | 400 | $25K | 1.4% |
| Total | $58.37 avg | 30,274 | $1.8M | 100% |
| Filing → |
| DCPH | SELL | 2019-12-13 | $902K | — | Filing → |
| DCPH | SELL | 2019-12-11 | $827K | — | Filing → |
| DCPH | SELL | 2019-12-05 | $752K | — | Filing → |